Tag:
drug development
Latest Headlines
Latest Headlines
Icon snatches up drug pricing guru PriceSpective
Dublin-based CRO Icon has snatched up PriceSpective, a 9-year-old consulting firm focused on market access, reimbursement and pharmaceutical pricing. Neither side is disclosing financial terms in...
University Hospitals launches drug discovery/commercialization enterprise
Ladies and gentlemen, the world now has its latest drug discovery initiative--the Harrington Project for Discovery & Development. Plans call for $250 million in backing to fuel early-stage...
Aesica CEO Hardy makes CDMO business fly
As the bumble bee doesn't know it shouldn't be able to fly, so Aesica Pharmaceuticals CEO Rob Hardy is unaware that the West can't compete with the East in high-volume pharma manufacturing. The
Harvard project takes aim at improving drug development odds
For all the much-vaunted scientific effort that goes into drug development, biotech companies and their scientific teams are often shining a light on only one narrow cellular target. Often a new drug
Flying high on Elan deal, Alkermes gets to work on Big Pharma project
Alkermes ( $ALKS ) is taking immediate occupancy of an Elan Drug Technologies' Athalone, Ireland, facility following its $1 billion acquisition of the latter's drug technology business. Alkermes
Patheon reveals strategy amid poor financials
James Mullen, the former CEO of Biogen Idec ( $BIIB ), is facing some new challenges at the helm of contract manufacturing outfit Patheon ($TSX:PTI). Mullen, who stepped up as CEO and president in
Time to put the innovation into manufacturing
Recent drug discoveries and subsequent development failures have led some--investors and drugmakers among them--to question pharma's ability to innovate within the constraints of the current business
A recipe for drug variation: Just add sugar
We know that sugar has the potential to sweeten drug development by altering the behavior of potential and existing drugs, giving pharmacologists a box that contains a wider variety of tools. For
Open source drug discovery for the developing world
Lori Mehen, an account manager at Red Hat, writes in opensource.com that the future of pharma is open source--particularly when it comes to drug development for the developing world. She mentions, in
Necessity driving leery pharma "open"
PHOENIX -- It's almost as if the topic were taboo: the open-source concept in drug development gets little play in the agenda at the Partnerships in Clinical Trials conference. The topic had a way of
